Justin Stebbing to Treatment Outcome
This is a "connection" page, showing publications Justin Stebbing has written about Treatment Outcome.
Connection Strength
0.116
-
Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals. Ann Rheum Dis. 2021 09; 80(9):1245-1246.
Score: 0.034
-
Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancer. Expert Rev Anticancer Ther. 2018 06; 18(6):531-541.
Score: 0.027
-
Fasting: starving cancer. Lancet Oncol. 2017 04; 18(4):431.
Score: 0.025
-
Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection. Ann Surg. 2021 07 01; 274(1):e1-e9.
Score: 0.009
-
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert Opin Drug Saf. 2020 Nov; 19(11):1505-1511.
Score: 0.008
-
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. J Natl Cancer Inst. 2018 06 01; 110(6):560-567.
Score: 0.007
-
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015 Jul; 152(2):231-7.
Score: 0.006